ANDAOPHTHALMICOINTMENT
Approved
Jan 1995
Lifecycle
Post-LOE
Competitive Pressure
30/100
Mechanism of Action
CLINICAL PHARMACOLOGY Polymyxin B sulfate attacks gram-negative bacilli, including virtually all strains of Pseudomonas aeruginosa and Haemophilus influenzae species. Bacitracin is active against most gram-positive bacilli and cocci including hemolytic streptococci.